title: R-CHOP therapy for MALT lymphoma of the rectum.
authors.forename: Dai
authors.initials: D
authors.lastname: Chihara
authors.forename: Yoshitoyo
authors.initials: Y
authors.lastname: Kagami
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Oki
authors.forename: Harumi
authors.initials: H
authors.lastname: Kato
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Onoda
authors.forename: Shouji
authors.initials: S
authors.lastname: Ine
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Taji
authors.forename: Kazuhito
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Morishima
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D012004:Rectal Neoplasms / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D012074:Remission Induction; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone